Kenneth Attie
VP at Eli Lilly, CMO at Versanis Bio
- Role
- Vice President, Clinical Research, Cardiometabolic Health at Eli Lilly and Company
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Kenneth Attie
Chief medical officer for biotech/biopharma, with 30+ years experience in Phase I-IV clinical development, leading to approvals for 5 drugs in 8 indications.Pediatric endocrinologist with expertise in endocrine/metabolic disease, neuromuscular disease, and benign hematologic disorders, among others.Trained at NYU and UCSF medical centers.
Experience
Vice President, Clinical Research, Cardiometabolic Health
Jan 2024 — Present · Boston, MA, US
Education
NYU Grossman School of Medicine
MD, Medicine
1978 — 1982
Manhattan School of Music
Cello
1974 — 1975
University of Michigan
BA, Music
1975 — 1978
Skills
- Pharmaceutical Industry
- Fda
- Life Sciences
- Ctms
- Biotechnology
- CRO
- Oncology
- Drug Development
- Clinical Trials
- Gcp
- Medical Devices
- Clinical Research
- Regulatory Submissions
- Diabetes
- Regulatory Affairs
- Lifesciences
- Drug Discovery
- Clinical Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.